FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Cohen Jon R 2. Date of Event Requiring Statement (MM/DD/YYYY)
7/23/2020 

3. Issuer Name and Ticker or Trading Symbol OPKO HEALTH, INC. [OPK]
(Last)       (First)       (Middle)
4400 BISCAYNE BLVD.
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
SVP OPKO; Exec Chairman BRLI /
(Street)
MIAMI, FL 33137      
(City)             (State)             (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock  75000  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)   (1) 1/6/2029  Common Stock  500000  $3.67  D   
Stock Option (Right to Buy)   (2) 9/16/2029  Common Stock  100000  $2.17  D   
Stock Option (Right to Buy)   (3) 6/3/2030  Common Stock  1500000  $2.27  D   

Explanation of Responses:
(1)  This option will vest in four equal annual installments beginning January 7, 2020; provided, however, that one-half of the options (250,000 shares) will require achievement of predefined performance goals measured during each year during the four year vesting period in order to be exercisable.
(2)  This option will vest in four equal annual installments beginning September 17, 2020.
(3)  This option will vest in four equal annual installments beginning June 4, 2021.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Cohen Jon R
4400 BISCAYNE BLVD.
MIAMI, FL 33137
X
SVP OPKO; Exec Chairman BRLI

Signatures
Steven D. Rubin, Attorney-in-Fact 7/24/2020
**Signature of Reporting Person Date
Opko Health (NASDAQ:OPK)
Historical Stock Chart
From Nov 2020 to Dec 2020 Click Here for more Opko Health Charts.
Opko Health (NASDAQ:OPK)
Historical Stock Chart
From Dec 2019 to Dec 2020 Click Here for more Opko Health Charts.